Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Eli Lilly has agreed to buy hearing loss gene therapy developer Akouos in a deal that could value the company at around $610 million – if its lead candidate progresses as hoped in the clinic.

Eli Lilly projects that sales in 2025 will reach between $58 billion and $61 billion. The company’s stock price has surged over 200% in the past three years. It currently has a market cap of ...